68Ga-PSMA I&T is characterized by rapid tumor targeting (4.95 ± 1.57 % IA/g at 1 h p.i.)and pharmacokinetics with high uptake in PSMA-positive organs such as the tumor and the kidneys (53.26 ± 9.02 % IA/g at 1 h p.i.). The gene discussed is FOLH1; the disease is neoplasm.